Prakash Sanjay, Patel Payal
Department of Neurology, Smt. B. K. Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth University, Vadodara, Gujarat, India.
Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH, USA.
J Pain Res. 2017 Jun 29;10:1493-1509. doi: 10.2147/JPR.S128472. eCollection 2017.
Hemicrania continua (HC) is an indomethacin-responsive primary headache disorder which is currently classified under the heading of trigeminal autonomic cephalalgias (TACs). It is a highly misdiagnosed and underreported primary headache. The pooled mean delay of diagnosis of HC is 8.0 ± 7.2 years. It is not rare. We noted more than 1000 cases in the literature. It represents 1.7% of total headache patients attending headache or neurology clinic. Just like other TACs, it is characterized by strictly unilateral pain in the trigeminal distribution, cranial autonomic features in the same area and agitation during exacerbations/attacks. It is different from other TACs in one aspect. While all other TACs are episodic, HC patients have continuous headaches with superimposed severe exacerbations. The central feature of HC is continuous background headache. However, the patients may be worried only for superimposed exacerbations. Focusing only on exacerbations and ignoring continuous background headache are the most important factors for the misdiagnosis of HC. A large number of patients may have migrainous features during exacerbation phase. Up to 70% patients may fulfill the diagnostic criteria for migraine during exacerbations. Besides migraine, its exacerbations can mimic a large number of other primary and secondary headaches. The other specific feature of HC is a remarkable response to indomethacin. However, a large number of patients develop side effects because of the long-term use of indomethacin. A few other medications may also be effective in a subset of patients with HC. Various surgical interventions have been suggested for patients who are intolerant to indomethacin. Several aspects of HC are still not defined. There is a great heterogeneity in types of patients or articles on the HC in the literature. Diagnostic criteria have been modified several times over the years. The current diagnostic criteria are too restrictive in some aspects. We suggest a more accommodating type of criteria for the appendix of International Classification of Headache Disorder (ICHD).
持续性偏侧头痛(HC)是一种对吲哚美辛敏感的原发性头痛疾病,目前归类于三叉自主神经性头痛(TACs)。它是一种极易被误诊且报告不足的原发性头痛。HC诊断的汇总平均延迟时间为8.0±7.2年。它并不罕见。我们在文献中注意到超过1000例病例。它占头痛或神经科门诊就诊的头痛患者总数的1.7%。与其他TACs一样,其特点是三叉神经分布区域严格单侧疼痛、同一区域的颅自主神经特征以及发作/加重期间的烦躁不安。它在一个方面与其他TACs不同。虽然所有其他TACs都是发作性的,但HC患者有持续性头痛并伴有严重的叠加加重。HC的核心特征是持续性背景性头痛。然而,患者可能仅对叠加的加重情况感到担忧。仅关注加重情况而忽略持续性背景性头痛是HC误诊的最重要因素。大量患者在加重期可能有偏头痛特征。高达70%的患者在加重期可能符合偏头痛的诊断标准。除了偏头痛,其加重情况还可模仿大量其他原发性和继发性头痛。HC的另一个特点是对吲哚美辛有显著反应。然而,大量患者因长期使用吲哚美辛而出现副作用。其他一些药物对部分HC患者也可能有效。对于不耐受吲哚美辛的患者,已提出了各种手术干预措施。HC的几个方面仍未明确。文献中关于HC的患者类型或文章存在很大的异质性。多年来诊断标准已多次修改。目前的诊断标准在某些方面过于严格。我们建议为《国际头痛疾病分类》(ICHD)附录制定一种更宽松的标准。